TrueRoll and DEVNET Partner to Streamline Homestead Exemption Processing
Strategic collaboration helps assessor offices reduce manual workloads and simplify exemption workflows through integrated automation. CHICAGO, June 17, 2025 /PRNewswire/... Read more.
Inveniam Appoints Paul Soanes as Chief Commercial Officer
Veteran Operator and Clean Energy Entrepreneur to Lead Commercial Strategy for Tokenized Private Market Infrastructure NEW YORK, June 17, 2025 /PRNewswire/ —... Read more.
Ramp Raises $200M Series E at $16B Valuation as Companies of All Sizes Choose AI-Powered Finance Platform
Round led by Founders Fund as 40,000 customers drive more than $80B in payment volume NEW YORK, June 17, 2025 /PRNewswire/ — Ramp, the leading financial operations... Read more.
Gen Mobile Helps Bridge the Digital Divide as a Leading Lifeline Program Provider Across the U.S. and Tribal Lands
EL SEGUNDO, Calif., June 17, 2025 /PRNewswire/ — Gen Mobile, a leading provider of prepaid wireless phone service, today announced the launch of its federal... Read more.
Exiger CMO Kody Gurfein Wins PRNews’ Top Women Award
Gurfein Recognized in ‘Industry Champions’ Category, Alongside Executives from Wells Fargo and U.S. Navy WASHINGTON, June 17, 2025 /PRNewswire/ — Exiger,... Read more.
Relentless Digital Named to Inc.’s Best Places to Work 2025
Recognition highlights a culture built on trust, growth, and people-first values QUEEN CREEK, Ariz., June 17, 2025 /PRNewswire/ — Relentless Digital, specializing... Read more.
SimpliSafe’s Award-Winning Outdoor Security Camera Series 2 Now Available at Major U.S. Retailers
The AI-powered Outdoor Security Camera Series 2 pairs with SimpliSafe® Active Guard Outdoor Protection for a double layer of defense that helps prevent crime before... Read more.
Integral Molecular Out-Licenses First-in-Class Antibody Panel Targeting SLC2A4 Glucose Transporter
PHILADELPHIA, June 17, 2025 /PRNewswire/ — Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce... Read more.
Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome
Drug candidate ATR12-351 has been generally safe and well-tolerated with occasional, transient, mild to moderate symptoms at application site Trial is 50% enrolled;... Read more.
Latent AI Launches Industry’s First Agentic Edge AI Platform to Streamline MLOps
Latent Agent Eliminates Model-to-Hardware Guessing Game, Reduces Complexity and Streamlines Management and Security of AI Infrastructure at Scale PRINCETON, N.J.,... Read more.